Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current strategies in engaging oncolytic viruses with antitumor immunity

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.05.002Source: DataRank Database

Current strategies in engaging oncolytic viruses with antitumor immunity is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.97)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Divya Ravirala ORCID,Shaun Xiaoliu Zhang,Drew Boagni ORCID

Live enrichment

PubMed:34514092 PMC:PMC8411207 OpenAlex:https://openalex.org/W3161072505

National Institutes of Health

Grant: R01CA187923

National Institutes of Health

Grant: R01CA203852

Cancer Prevention and Research Institute of Texas

Grant: RP200464

National Institutes of Health

Grant: 5R01CA203852-03

Reconstruction of an oncolytic HSV vector for systemic delivery

National Institutes of Health

Grant: 5R01CA187923-02

Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus

William and Ella Owens Medical Research Foundation

FWCI

3.97

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S2372770521000681/pdf

publisherhttp://www.cell.com/article/S2372770521000681/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2372770521000681?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2372770521000681?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omto.2021.05.002

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in Insects0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Oncolytic virusVirologyImmunityVirotherapyMedicineImmunologyBiologyVirusImmune systemNeoplasms. Tumors. Oncology. Including cancer and carcinogensReviewRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Current strategies in engaging oncolytic viruses with antitumor immunity

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)